P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring.

Kumara, H M C Shantha; Bellini, Geoffrey A; Caballero, Otavia L; Herath, Sonali A C; Su, Tao; Ahmed, Aqeel; Njoh, Linda; Cekic, Vesna; Whelan, Richard L

Kumara, H M C Shantha; Bellini, Geoffrey A; Caballero, Otavia L; Herath, Sonali A C; Su, Tao; Ahmed, Aqeel; Njoh, Linda; Cekic, Vesna; Whelan, Richard L.

Kumara HMCS; Division of Colon and Rectal Surgery, Department of Surgery, Mount Sinai Roosevelt Hospital Center, New York, NY, USA.
Bellini GA; Division of Colon and Rectal Surgery, Department of Surgery, Mount Sinai Roosevelt Hospital Center, New York, NY, USA.
Caballero OL; Ludwig Institute for Cancer Research Ltd, New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering, New York, NY, USA.
Herath SAC; Current address: Orygen Biotecnologia S.A., São Paulo, Brazil.
Su T; Division of Colon and Rectal Surgery, Department of Surgery, Mount Sinai Roosevelt Hospital Center, New York, NY, USA.
Ahmed A; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
Njoh L; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
Cekic V; Division of Colon and Rectal Surgery, Department of Surgery, Mount Sinai Roosevelt Hospital Center, New York, NY, USA.
Whelan RL; Division of Colon and Rectal Surgery, Department of Surgery, Mount Sinai Roosevelt Hospital Center, New York, NY, USA.